A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Status:
Recruiting

Trial end date:
2027-06-25

Target enrollment:

Participant gender:

This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.

Phase 3

Hoffmann-La Roche

Chugai Pharmaceutical